Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04205630
Title SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Byondis B.V.

endometrial carcinoma


Trastuzumab Duocarmazine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.